Poliomyelitis, commonly known as polio, is a highly contagious viral disease that primarily affects young children. The causative agent invades the nervous system and can cause total paralysis within a matter of hours. The virus enters the body through the mouth and multiplies in the intestine. While many infected individuals experience no symptoms or mild illness, a small percentage suffer irreversible paralysis, usually in the legs. In severe cases, it leads to death by paralyzing the muscles responsible for breathing.
Polio is caused by the poliovirus, an enterovirus belonging to the Picornaviridae family. There are three wild poliovirus strains: type 1, type 2, and type 3. Immunity to one strain does not protect against the others.
Once inside the body, the poliovirus multiplies in the pharynx and intestinal mucosa, then migrates to the regional lymph nodes. From the lymphatic system, it enters the bloodstream, a stage called viraemia. In a small fraction of cases, the virus crosses the blood-brain barrier and attacks the anterior horn cells of the spinal cord and the brainstem.
The destruction of these motor neurons interrupts nerve signals to muscles, causing flaccid paralysis. Clinical signs range from asymptomatic infection to non-paralytic aseptic meningitis, and finally paralytic poliomyelitis characterized by asymmetric, sudden muscle weakness and loss of reflexes.
Assessing a patient with suspected polio requires a detailed history regarding vaccination status, travel, and recent gastrointestinal illnesses. Nurses must perform thorough neurological assessments, checking for muscle tone, deep tendon reflexes, and symmetrical strength.
Stool samples remain the gold standard for isolating the poliovirus, collected within the first fourteen days of paralysis onset. Throat swabs can also yield positive viral cultures. Cerebrospinal fluid analysis typically shows elevated protein levels with normal or slightly increased white blood cells.
There is no known cure for poliomyelitis once the infection takes hold. Medical management is entirely supportive, focusing on preventing complications and managing symptoms to improve comfort and long-term functional outcomes.
Immunization is the single most effective tool to prevent poliomyelitis. Nigeria utilizes both the Oral Polio Vaccine (OPV) and the Inactivated Polio Vaccine (IPV). Maintaining the cold chain is vital, particularly in tropical climates like Nigeria, to preserve vaccine potency. OPV is heat-sensitive and requires storage between +2°C and +8°C, while IPV must never be allowed to freeze.
Vaccine Vial Monitors (VVMs) are affixed to vaccine labels to help health workers check if the vaccine has been exposed to damaging heat over time.
Community health nurses play a frontline role in sustaining polio-free status through active surveillance and health education. Nurses conduct Acute Flaccid Paralysis (AFP) surveillance, meaning every case of sudden flaccid weakness in children under fifteen must be reported and investigated immediately.
Nurses also debunk myths within local communities, address vaccine hesitancy, and mobilize families during supplemental immunization campaigns. Grassroots engagement ensures high coverage rates and builds trust in public health initiatives.